Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hans Garmo

Showing results (41-50 of 261) with videos related to

Pageof 27
Sort By:
Scandinavian Journal of Urology|December 23, 2021
Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancerRolf Gedeborg, Lars Lindhagen, Stacy Loeb, et al.
European Urology|January 9, 2016
Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer TreatmentStacy Loeb, Yasin Folkvaljon, David Robinson, et al.
Upsala Journal of Medical Sciences|November 10, 2011
Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly menLars Berglund, Christian Berne, Kurt Svärdsudd, et al.
Breast Cancer Research and Treatment|February 11, 2023
Estrogen therapy after breast cancer diagnosis and breast cancer mortality riskMaria Sund, Hans Garmo, Anne Andersson, et al.
European Urology Open Science|June 1, 2026
Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical ProstatectomyPietro Scilipoti, Max Callenmark, Hans Garmo, et al.
Journal of the National Cancer Institute|January 17, 2025
Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based studyPietro Scilipoti, Hans Garmo, Rolf Gedeborg, et al.
European Urology|June 14, 2011
Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe SwedenOlof Akre, Hans Garmo, Jan Adolfsson, et al.
The Breast Journal|January 29, 2020
Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control studyAntonis Valachis, Hans Garmo, Irma Fredriksson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causesBirgitta Grundmark, Hans Garmo, Massimo Loda, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2025
Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activityUlf Strömberg, Carl Bonander, Hans Garmo, et al.
Pageof 27

Showing results (41-50 of 261) with videos related to

Sort By:
Pageof 27
Scandinavian Journal of Urology|December 23, 2021
Androgen deprivation therapy, comorbidity, cancer stage and mortality from COVID-19 in men with prostate cancerRolf Gedeborg, Lars Lindhagen, Stacy Loeb, et al.
European Urology|January 9, 2016
Phosphodiesterase Type 5 Inhibitor Use and Disease Recurrence After Prostate Cancer TreatmentStacy Loeb, Yasin Folkvaljon, David Robinson, et al.
Upsala Journal of Medical Sciences|November 10, 2011
Seasonal variations of insulin sensitivity from a euglycemic insulin clamp in elderly menLars Berglund, Christian Berne, Kurt Svärdsudd, et al.
Breast Cancer Research and Treatment|February 11, 2023
Estrogen therapy after breast cancer diagnosis and breast cancer mortality riskMaria Sund, Hans Garmo, Anne Andersson, et al.
European Urology Open Science|June 1, 2026
Estimation and Prognostic Role of Prostate-specific Antigen (PSA) Doubling Time After Radical ProstatectomyPietro Scilipoti, Max Callenmark, Hans Garmo, et al.
Journal of the National Cancer Institute|January 17, 2025
Incidence and prognostic implications of prostate-specific antigen persistence and relapse after radical prostatectomy: population-based studyPietro Scilipoti, Hans Garmo, Rolf Gedeborg, et al.
European Urology|June 14, 2011
Mortality among men with locally advanced prostate cancer managed with noncurative intent: a nationwide study in PCBaSe SwedenOlof Akre, Hans Garmo, Jan Adolfsson, et al.
The Breast Journal|January 29, 2020
Bleeding risk in breast cancer patients during concomitant administration of warfarin and tamoxifen: A population-based nested case-control studyAntonis Valachis, Hans Garmo, Irma Fredriksson, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 22, 2010
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causesBirgitta Grundmark, Hans Garmo, Massimo Loda, et al.
Acta Oncologica (Stockholm, Sweden)|May 16, 2025
Sociodemographic disparities in incidence rates of advanced and low-risk prostate cancer as a proxy for diagnostic activityUlf Strömberg, Carl Bonander, Hans Garmo, et al.
Pageof 27